To determine the exact dose of rabies immunoglobulin for local wound management of animal bite in children and adolescents.
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: A829- Rabies, unspecified
- Registration Number
- CTRI/2021/01/030409
- Lead Sponsor
- Department of Pediatrics Maulana Azad Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All the children age between 2 to 18 yrs reporting to animal bite clinic for the first time.
Exclusion Criteria
Children who have already received rabies immunoglobulin in any time in the past.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The quantity of RIG infiltrated in relation to the size of the    <br/ ><br>wound.Timepoint: ONE YEAR
- Secondary Outcome Measures
Name Time Method /ATimepoint: N/A
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of rabies immunoglobulin (RIG) are critical for neutralizing rabies virus in pediatric populations?
How does the efficacy of rabies immunoglobulin compare to standard-of-care post-exposure prophylaxis in children and adolescents with animal bites?
Are there specific biomarkers that correlate with improved outcomes following RIG administration in rabies-exposed pediatric patients?
What are the potential adverse events associated with rabies immunoglobulin in children and how can they be managed?
What combination approaches or alternative therapies are being explored alongside RIG for rabies prevention in young patients?